ArticleFrontiers in immunology2024

Azithromycin targets the CD27 pathway to modulate CD27hi T-lymphocyte expansion and type-1 effector phenotype.

Abdul Wahid Ansari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.